EMA – Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) multistakeholder workshop on Patient Registries for Alzheimer’s disease – 15 December 2025
This joint hybrid HMA/EMA workshop on Patient Registries follows on the successful disease-specific workshops held between 2017 and 2019, as well as the EMA multi-stakeholder workshop on qualification of Patient Registries held in 2024.
The event brings together representatives of registry holders, regulatory agencies, pharmaceutical companies, patients, healthcare professionals, academia and non-for-profit research organisations, health technology assessment bodies and payers to explore how we can work all together to foster the use of registry data for regulatory decision-making in the field of Alzheimer’s Disease.
More specifically, the main objectives of the workshop are to agree on recommendations for optimising stakeholders’ collaboration to facilitate the long-term follow-up of patients using registries, and enable the generation of meaningful evidence on the safety and effectiveness of medicines using patient registries.
More information on this event on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (11 décembre 2025). EMA – Joint Heads of Medicines Agencies (HMA)/European Medicines Agency (EMA) multistakeholder workshop on Patient Registries for Alzheimer’s disease – 15 December 2025. ELSIBI. Consulté le 5 mars 2026 à l’adresse https://doi.org/10.58079/15bva





